Skip to main content

Table 1 Baseline characteristics of children upon enrolment for artemether-lumefantrine (AL) and dihydroartemisinin-piperaquine (DP), western Kenya 2011

From: A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya

Characteristic

AL (nā€‰=ā€‰137)(95% CI)

DP (nā€‰=ā€‰137)(95% CI)

p-value

Mean age (months)

36.1 (33.8ā€“38.5)

33.5 (31.1ā€“35.9)

0.11

Male (%)

55

57

0.9

Mean weight (kg)

13.3 (12.8ā€“13.8)

13.0 (12.5ā€“13.4)

0.3

Mean axillary temperature (Ā°C)

37.6 (37.4ā€“37.8)

37.7 (37.5ā€“38.0)

0.35

Mean haemoglobin (g/dL)

9.7 (9.4ā€“10.0)

9.9 (9.7ā€“10.2)

0.28

Geometric mean day 0 parasite density (parasites/ Ī¼L) (range)

45,168 (34,506ā€“47,190) (10ā€“148,027)

49,248 (35,188ā€“52,544) (54ā€“166,584)

0.49